3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Prostatic Neoplasms
6
Carcinoma, Renal Cell
5
Brain Neoplasms
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Kidney Neoplasms
2
Glioma
2
Glioblastoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Thyroid cancer, medullary
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pain
1
Osteosarcoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Interventions
Flow Cytometry
2
talactoferrin alfa
1
perifosine
1
cabozantinib
1
antineoplaston AS 2-1
1
antineoplaston A10
1
alovudine
1
alectinib
1
Vorinostat
1
Trastuzumab
1
Tissue Array Analysis
1
Taxes
1
Sunitinib
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Polymerase Chain Reaction
1
Paclitaxel
1
Oxaliplatin
1
Oligonucleotide Array Sequence Analysis
1
Microarray Analysis
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Immunohistochemistry
1
Immunoenzyme Techniques
1
Gene Expression Profiling
1
Fluorodeoxyglucose F18
1
Fluorescent Antibody Technique
1
Everolimus
1
Electroacupuncture
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Salivary Gland Neoplasms
×
cabozantinib
×
Clear all
NCT03729297
2021-03-12
Cabo ASAP
Radboud University Medical Center
Phase 2
Terminated
25 enrolled